Abstract
Skin has received considerable attention for vaccination in the past decade owing to its rich in antigen-presenting cells (APCs) and better immune responses as compared to the muscle. Vaccination via the skin instead of the muscle may also make it possible to develop safer adjuvants and needle-free delivery systems. In the past 5 years we have developed a novel laser-based vaccine adjuvant (LVA) in which the inoculation site is briefly illuminated by a safe laser that enhances the motility and antigen-uptake of APCs. The brief illumination also facilitates emigration of APCs from the skin to draining lymph nodes. While greatly enhancing vaccination efficacies, LVA exhibits minimal local side effects and has no long-term side effects since no foreign or self materials are administered into the body apart from antigen itself. This novel strategy primes the inoculation site for better immune responses, in contrast to conventional vaccine adjuvants that all augment the immunogenicity by altering a form of the antigens. As such, LVA doesn’t require any formation with the antigen and can potentially act as a universal vaccine adjuvant. Indeed, this physical type LVA can sufficiently boost immune responses induced by ovalbumin (OVA), influenza vaccine, nicotine vaccine, and so on. Besides LVA, we have also explored a laser-facilitated patch delivery system for needle-free, painless transcutaneous immunization. The system is based on ablative fractional laser (AFL) treatment to generate an array of self-renewable microchannels (MCs) in the skin, through which topically applied vaccines can enter the skin readily. The laser treatment also results in active recruitment of APCs to the vicinity of each MC where APCs can more effectively take up antigens around or within the MCs, leading to ~100 times higher immune response against OVA than tape stripping-based patch delivery. In this chapter, we introduce these technologies and their preclinical studies and discuss their strengths and weaknesses.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Barraclough, K.A., et al.: Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am. J. Kidney Dis. 54, 95–103 (2009)
Belshe, R.B., et al.: Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286–2294 (2004)
Beran, J., et al.: Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 7, 13 (2009)
Kenney, R.T., Frech, S.A., Muenz, L.R., Villar, C.P., Glenn, G.M.: Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351, 2295–2301 (2004)
Lofquist, J.M., Weimert, N.A., Hayney, M.S.: Smallpox: a review of clinical disease and vaccination. Am. J. Health Syst. Pharm. 60, 749–756 (2003)
Kim, Y.C., Jarrahian, C., Zehrung, D., Mitragotri, S., Prausnitz, M.R.: Delivery systems for intradermal vaccination. Curr. Top. Microbiol. Immunol. 351, 77–112 (2012)
Liu, L., et al.: Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat. Med. 16, 224–227 (2010)
Chen, X., Wu, M.X.: Laser vaccine adjuvant for cutaneous immunization. Expert Rev. Vaccines 10, 1397–1403 (2011)
Chen, X., et al.: A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS One 5, e13776 (2010)
Chen, X., Zeng, Q., Wu, M.X.: Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination. Clin. Cancer Res. 18, 2240–2249 (2012)
Li, N., Peng, L.H., Chen, X., Nakagawa, S., Gao, J.Q.: Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine 29, 6179–6190 (2011)
Chen, X., et al.: Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J. Control. Release 159(1), 43–51 (2012)
Lee, W.R., et al.: Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J. Control. Release 128, 200–208 (2008)
Manstein, D., Herron, G.S., Sink, R.K., Tanner, H., Anderson, R.R.: Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg. Med. 34, 426–438 (2004)
Chen, G.Y., Nunez, G.: Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826–837 (2010)
Cornuz, J., et al.: A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One 3, e2547 (2008)
Hatsukami, D.K., et al.: Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin. Pharmacol. Ther. 89, 392–399 (2011)
Pentel, P.R., et al.: A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol. Biochem. Behav. 65, 191–198 (2000)
Fahim, R.E., Kessler, P.D., Fuller, S.A., Kalnik, M.W.: Nicotine vaccines. CNS Neurol. Disord. Drug Targets 10, 905–915 (2011)
Prausnitz, M.R., Mikszta, J.A., Cormier, M., Andrianov, A.K.: Microneedle-based vaccines. Curr. Top. Microbiol. Immunol. 333, 369–393 (2009)
Matriano, J.A., et al.: Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19, 63–70 (2002)
Taberner, A.J., Ball, N.B., Hogan, N.C., Hunter, I.W.: A portable needle-free jet injector based on a custom high power-density voice-coil actuator. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1, 5001–5004 (2006)
Hingson, R.A., Davis, H.S., Bloomfield, R.A., Brailey, R.F.: Mass inoculation of the Salk polio vaccine with the multiple dose jet injector. GP 15, 94–96 (1957)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chen, X., Wu, M.X. (2014). Laser for Skin Vaccine Delivery and Adjuvantation. In: Giese, M. (eds) Molecular Vaccines. Springer, Cham. https://doi.org/10.1007/978-3-319-00978-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-00978-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-00977-3
Online ISBN: 978-3-319-00978-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)